Blue Crest Capital Management LTD Albemarle Corp Transaction History

Blue Crest Capital Management LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$214.16 - $283.8 $312,673 - $414,348	-1,460 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$167.91 - $244.03 $245,148 - $356,283	1,460 New	1,460 $320,000
Q1 2019 May 15, 2019	SELL	$72.69 - $92.28 $254,487 - $323,072	-3,501 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$73.13 - $107.99 $20,330 - $30,021	-278 Reduced 7.36%	3,501 $270,000
Q3 2018 Nov 14, 2018	BUY	$90.9 - $106.6 $343,511 - $402,841	3,779 New	3,779 $377,000
Q4 2017 Feb 14, 2018	SELL	$127.48 - $144.58 $1.86 Million - $2.1 Million	-14,554 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$109.36 - $136.31 $1.59 Million - $1.98 Million	14,554	14,554 $1.98 Million

946

109M

6.73M

10.4M

Ticker ALB
Exchange NYSE
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 117,129,000
Market Cap $11.3B
Description
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Blue Crest Capital Management LTD with notifications on news.